Health Catalyst Inc is a leading provider of data and analytics technology for healthcare organizations, focused on improving clinical and financial outcomes through its innovative solutions
By leveraging a robust data platform, the company enables healthcare providers to aggregate, analyze, and visualize their data, facilitating better decision-making and operational efficiencies. Health Catalyst's suite of applications and services supports organizations in their journey towards value-based care by enhancing performance improvement initiatives, driving better patient outcomes, and optimizing healthcare delivery systems. Ultimately, the company's mission is to empower healthcare organizations with the insights and tools needed to transform the industry and enhance the quality of care.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Palantir (NASDAQPLTR) and the rest of the data analytics stocks fared in Q3.
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (NASDAQHCAT) and its peers.
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the data analytics industry, including Samsara (NYSEIOT) and its peers.
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Amplitude (NASDAQAMPL) and its peers.
Over the past six months, Health Catalyst has been a great trade, beating the S&P 500 by 7.9%. Its stock price has climbed to $7.09, representing a healthy 17.2% increase. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Data visualization and business intelligence company Domo (NASDAQDOMO)
will be reporting earnings tomorrow after the bell. Here’s what you need to know.
Healthcare software provider Health Catalyst (NASDAQHCAT) met Wall Street’s revenue expectations in Q3 CY2024, with sales up 3.5% year on year to $76.35 million. The company expects next quarter’s revenue to be around $81 million, close to analysts’ estimates. Its non-GAAP profit of $0.07 per share was 25.4% below analysts’ consensus estimates.
